Puerarin has been reported to have a chemopreventive effect on colon cancer HT-29 cells by reducing cell viability, inducing apoptosis, activating Bax and caspase 3, and inhibiting c-Myc and Bcl-2 [21]. The gene discussed is BAX; the disease is colonic neoplasm.